Investors

Announcements

06-Apr-2023	Intimation of revision of Credit Rating
30-Mar-2023	Intimation of Conversion of the Company
21-Mar-2023	Intimation of Trading Window Closure
17-Feb-2023	Newspaper Publication of Financial Results-Dec 2022
13-Feb-2023	Certificate of Interest Payment
08-Feb-2023	Intimation of Resignation of Director – Mr. G V Sanjay Reddy
08-Feb-2023	Intimation of Resignation of Director – Mr. Adam Richard Dawson
08-Feb-2023	Notice of Board Meeting-13.02.2023
27-Jan-2023	Proceedings of EGM
25-Jan-2023	Outcome of the Board Meeting – 25.01.2023
10-Jan-2023	Intimation of Record Date for Interest Payment
21-Dec-2022	Intimation of Trading Window Closure
02-Dec-2022	Intimation of Appointment of Director in EGM-Ms. Anita Ramachandran
02-Dec-2022	Proceedings of EGM
9-Nov-2022	Newspaper Publication of Financial Results dated 07.11.2022_Sep 2022
07-Nov-2022	Intimation of ESOP Plan 2022
07-Nov-2022	Intimation of Appointment of Director-Ms. Anita Ramachandran
02-Nov-2022	Notice of Board Meeting-07.11.2022 & 08.11.2022
21-Sep-2022	Intimation of Trading Window Closure
24-Aug-2022	Proceedings of 21st AGM
08-Aug-2022	Newspaper Publication of Financial Results dated 05.08.2022_June 2022
28-Jul-2022	Notice of Board Meeting-03.08.2022
22-Jun-2022	Intimation of Trading Window Closure
10-Jun-2022	Intimation of Approval of Composite Scheme
10-Jun-2022	Intimation of Resignation of Director – Mr. Sahajbir Singh
03-Jun-2022	Intimation of Resignation of Director
30-May-2022	Newspaper Publication of Financial Results dated 28.05.2022_May 2022
23-May-2022	Notice of Board Meeting – 26.05.2022
12-May-2022	Statement of Utilization of Issue Proceeds of NCDs
23-Mar-2022	Intimation of Trading Window Closure
15-Mar-2022	Intimation of Policy for fair disclosure of Unpublished Price Sensitive Information (UPSI)

Financial Results

December-2022	Financial Result – December 2022
September-2022	Financial Result – September 2022
June-2022	Financial Result – June 2022
March-2022	Revised Financial Result – March 2022
March-2022	Financial Result – March 2022

Annual Reports

Annual Report 2021-22

Annual Returns

Annual Return 2021-22

Policies

Policy for Dividend Distribution

Policy for Preservation of Documents

Code of Conduct for Prevention of Insider Trading

Policy for fair disclosure of Unpublished Price Sensitive Information (UPSI)

Code of Conduct for Board of Directors and Senior Management

Policy on Determining Materiality for Disclosures

Policy on Material Subsidiaries

Policy on Materiality of and on dealing with RPTs

Whistle Blower Policy

Board Diversity Policy

Corporate Social Responsibility (CSR) Policy

Nomination and Remuneration Policy

Risk Management Policy

Credit Ratings

03-Apr-2023	Credit Rating_NCD_75 Crore
03-Apr-2023	Credit Rating_NCD_225 Crore
07-Apr-2022	Credit Rating_NCD_225 Crore
07-Apr-2022	Credit Rating_NCD_75 Crore
02-Feb-2022	Credit Rating_NCD_225 Crore
02-Feb-2022	Credit Rating_NCD_75 Crore

Investor Grievances

Mr. Ramakrishna Kasturi
Company Secretary, Director – Finance & Compliance
Aragen Life Sciences Pvt. Ltd.
28 A, IDA Nacharam
Hyderabad 500 076, India
+91 40 6692 9999
compliances@aragen.com

Debenture Trustee

Ms. Paridhi Doshi
IDBI Trusteeship Services Limited
Asian Building, Ground Floor
17, R. Kamani Marg, Ballard Estate
Mumbai-400001, India
+91 22 40807 000
itsl@idbitrustee.com